Foto del docente

Fulvia Farabegoli

Ricercatrice confermata

Dipartimento di Farmacia e Biotecnologie

Settore scientifico disciplinare: MED/04 PATOLOGIA GENERALE

Pubblicazioni

Farabegoli, Fulvia; Pinheiro, Marina, Epigallocatechin-3-Gallate Delivery in Lipid-Based Nanoparticles: Potentiality and Perspectives for Future Applications in Cancer Chemoprevention and Therapy, «FRONTIERS IN PHARMACOLOGY», 2022, 13, pp. 809706 - 809712 [articolo]

Rossi V.; Govoni M.; Farabegoli F.; Di Stefano G., Lactate is a potential promoter of tamoxifen resistance in MCF7 cells, «BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS», 2022, 1866, Article number: 130185, pp. 130185 - N/A [articolo]

Petrocelli, Giovannamaria; Farabegoli, Fulvia; Valerii, Maria Chiara; Giovannini, Catia; Sardo, Alberto; Spisni, Enzo, Molecules Present in Plant Essential Oils for Prevention and Treatment of Colorectal Cancer (CRC), «MOLECULES», 2021, 26, Article number: 885, pp. 1 - 12 [articolo]Open Access

Farooqi A.A.; Pinheiro M.; Granja A.; Farabegoli F.; Reis S.; Attar R.; Sabitaliyevich U.Y.; Xu B.; Ahmad A., EGCG mediated targeting of deregulated signaling pathways and non-coding rnas in different cancers: Focus on JAK/STAT, Wnt/β-catenin, TGF/SMAD, NOTCH, SHH/GLI, and TRAIL mediated signaling pathways, «CANCERS», 2020, 12, Article number: 951, pp. 951 - 971 [articolo]Open Access

Bagnolini G.; Milano D.; Manerba M.; Schipani F.; Ortega J.A.; Gioia D.; Falchi F.; Balboni A.; Farabegoli F.; De Franco F.; Robertson J.; Pellicciari R.; Pallavicini I.; Peri S.; Minucci S.; Girotto S.; Di Stefano G.; Roberti M.; Cavalli A., Synthetic Lethality in Pancreatic Cancer: Discovery of a New RAD51-BRCA2 Small Molecule Disruptor That Inhibits Homologous Recombination and Synergizes with Olaparib, «JOURNAL OF MEDICINAL CHEMISTRY», 2020, 63, pp. 2588 - 2619 [articolo]Open Access

Marinella Roberti, Fabrizio Schipani, Greta Bagnolini, Domenico Milano, Elisa Giacomini, Federico Falchi, Andrea Balboni, Marcella Manerba, Fulvia Farabegoli, Francesca De Franco, Janet Robertson, Saverio Minucci, Isabella Pallavicini, Giuseppina Di Stefano, Stefania Girotto, Roberto Pellicciari, and Andrea Cavalli, Rad51/Brca2 Disruptors Inhibit Homologous Recombination and Synergize with Olaparib in Pancreatic Cancer Cells, «EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY», 2019, 165, pp. 80 - 92 [articolo]

Farabegoli, Fulvia*; Govoni, Marzia; Spisni, Enzo; Papi, Alessio, Epigallocatechin-3-gallate and 6-OH-11-O-hydroxyphenanthrene limit BE(2)-C neuroblastoma cell growth and neurosphere formation in vitro, «NUTRIENTS», 2018, 10, pp. 1141 - 1157 [articolo]Open Access

Farabegoli, F.; Scarpa, E.S.; Frati, A.; Serafini, G.; Papi, A.; Spisni, E.; Antonini, E.; Benedetti, S.; Ninfali, P, Betalains increase vitexin-2-O-xyloside cytotoxicity in CaCo-2 cancer cells, «FOOD CHEMISTRY», 2017, 218, pp. 356 - 364 [articolo]Open Access

Farabegoli, Fulvia; Govoni, Marzia; Spisni, Enzo; Papi, Alessio, EGFR inhibition by (-)-epigallocatechin-3-gallate and IIF treatments reduces breast cancer cell invasion, «BIOSCIENCE REPORTS», 2017, 37, pp. 1 - 14 [articolo]Open Access

Falchi, Federico; Giacomini, Elisa; Masini, Tiziana; Boutard, Nicolas; Di Ianni, Lorenza; Manerba, Marcella; Farabegoli, Fulvia; Rossini, Lara; Robertson, Janet; Minucci, Saverio; Pallavicini, Isabella; Di Stefano, Giuseppina; Roberti, Marinella; Pellicciari, Roberto; Cavalli, Andrea, Synthetic Lethality Triggered by Combining Olaparib with BRCA2-Rad51 Disruptors, «ACS CHEMICAL BIOLOGY», 2017, 12, pp. 2491 - 2497 [articolo]

Papi, Alessio; Govoni, Marzia; Ciavarella, Carmen; Spisni, Enzo; Orlandi, Marina; Farabegoli, Fulvia, Epigallocatechin-3-gallate Increases RXRγ-mediated Pro-apoptotic and Anti-invasive Effects in Gastrointestinal Cancer Cell Lines, «CURRENT CANCER DRUG TARGETS», 2016, 16, pp. 373 - 385 [articolo]

Farabegoli F; Govoni M; Ciavarella C; Orlandi M; Papi A., A RXR ligand 6-OH-11-O-hydroxyphenanthrene with antitumour properties enhances (-)-epigallocatechin-3-gallate activity in three human breast carcinoma cell lines., «BIOMED RESEARCH INTERNATIONAL», 2014, 2014, Article number: 853086, pp. 1 - 13 [articolo]Open Access

A. Papi; F. Farabegoli; R. Iori; M. Orlandi; G.R. De Nicola; M. Bagatta ; D. Angelino; L. Gennari; P. Ninfali, Vitexin-2-O-xyloside, raphasatin and (-)-epigallocatechin-3-gallate synergistically affect cell growth and apoptosis of colon cancer cells, «FOOD CHEMISTRY», 2013, 138, pp. 1521 - 1530 [articolo]

Farabegoli F.; Vettraino M.; Manerba M.; Fiume L.; Roberti M.; Di Stefano G., Galloflavin, a new lactate dehydrogenase inhibitor, induces the death of human breast cancer cells with different glycolytic attitude by affecting distinct signaling pathways., «EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES», 2012, 47, pp. 729 - 738 [articolo]

Farabegoli F.; Papi A.; Orlandi M., (-)-Epigallocatechin-3-gallate down-regulates EGFR, MMP-2, MMP-9 and EMMPRIN and inhibits the invasion of MCF-7 tamoxifen-resistant cells., «BIOSCIENCE REPORTS», 2011, 31, pp. 99 - 108 [articolo]